Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
220 participants
INTERVENTIONAL
2009-01-31
2011-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Antenatal model
antenatal model
Antenatal model is consisted of integrated efforts to lower preterm delivery rate through early detection and bacterial vaginal infection treatment:
* Midwife training
* Pregnant women campaigning
* Early detection with self pH detection
* Treatment of bacterial vaginosis
Antenatal Model
antenatal model
Antenatal model is consisted of integrated efforts to lower preterm delivery rate through early detection and bacterial vaginal infection treatment:
* Midwife training
* Pregnant women campaigning
* Early detection with self pH detection
* Treatment of bacterial vaginosis
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
antenatal model
Antenatal model is consisted of integrated efforts to lower preterm delivery rate through early detection and bacterial vaginal infection treatment:
* Midwife training
* Pregnant women campaigning
* Early detection with self pH detection
* Treatment of bacterial vaginosis
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* singleton pregnancy, without any fetal or uterine anomaly
Exclusion Criteria
* Any history of disease in pregnancy
20 Years
40 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Indonesia University
OTHER
Showa University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Dept Obstetrics Gynecology, Indonesia University
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Ali Sungkar, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
Dept Obstetrics Gynecology, Indonesia University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Cipto Mangunkusumo National Hospital
Jakarta, Jakarta Special Capital Region, Indonesia
Countries
Review the countries where the study has at least one active or historical site.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Ali Sungkar, MD, PhD
Role: primary
Yuditiya Purwosunu, MD
Role: backup
References
Explore related publications, articles, or registry entries linked to this study.
Sungkar A, Purwosunu Y, Aziz MF, Pratomo H, Sutrisna B, Sekizawa A. Influence of early self-diagnosis and treatment of bacterial vaginosis on preterm birth rate. Int J Gynaecol Obstet. 2012 Jun;117(3):264-7. doi: 10.1016/j.ijgo.2012.01.007. Epub 2012 Mar 23.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
AACP09
Identifier Type: -
Identifier Source: org_study_id